Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

128.98 +2.21 (+1.74%)
Official Closing Price Updated: 4:15 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,841,110
Open 127.38
Bid (Size) 128.00 (3)
Ask (Size) 132.50 (1)
Prev. Close 126.77
Today's Range 127.01 - 129.05
52wk Range 104.29 - 138.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers. 
Via Talk Markets
3 Biotech Stocks to Avoid Like the Plague
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace

Performance

YTD
-0.82%
-0.82%
1 Month
-1.01%
-1.01%
3 Month
-0.25%
-0.25%
6 Month
-4.80%
-4.80%
1 Year
+10.71%
+10.71%

More News

Read More
Sunnier Skies This Past Week, But Will It Last?
Via Talk Markets
Technical And Fundamental Analysis On US Oil Fund
Via Talk Markets
Time To Play Small Cap Life Science Stocks
Via Talk Markets
Biotech ETFs Pop On M&A Resurgence
Via Talk Markets
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
Via Talk Markets
Healthcare Sector Update: MedTech Trending Up
Via Talk Markets
The Economic Modern Family & the MOST IMPORTANT Data Ever
Via Talk Markets
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Via Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Via Benzinga
Trillions In Biotech Stock Gains Trace Back To This Financier
Via Investor's Business Daily
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Via Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Via Benzinga
April Is Busting Out For Healthcare And Biotech
Via Talk Markets
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Via Benzinga
AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC's 'Final Trades'
Via Benzinga
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
Via Talk Markets
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Via Talk Markets
Market - What About The China/Russian BrahFest?
Via Talk Markets
US Judge Weighs Nationwide Ban On Abortion Pills
Via Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
Via Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Via Benzinga
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.